Exelixis Clinical Site #111

Madrid 28040

0 studies enrolling now · 2 studies all time

What they study most

Castration-resistant Prostate Cancer, Colorectal Cancer, Differentiated Thyroid Cancer, Endometrial Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Lower Esophageal Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer

Studies at this site

• Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors — Running, not enrolling
• Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Running, not enrolling